BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Drug Development

  Karyopharm Presents Positive Clinical Data On The Activity Of Selinexor In Combination With Other Anticancer Agents Across Multiple Hematologic Malignancies At The 2015 American Society of Hematology Annual Meeting

  December 7, 2015

   · 

  17 min read
• Business

  Neptune Technologies & Bioressources Inc. Announces Preliminary Q3 Results

  December 7, 2015

   · 

  4 min read
• Business

  The Wyss Institute And The Keepsmilin4abbie Foundation Join Forces Towards Early Detection And Treatment Of Anaphylaxis

  December 7, 2015

   · 

  6 min read
• Drug Development

  AbbVie Release: IMBRUVICA (Ibrutinib) Phase 3 RAY Data Show Significant Reductions In Disease Progression Versus Temsirolimus In Relapsed/Refractory Mantle Cell Lymphoma Patients

  December 7, 2015

   · 

  13 min read
• Regional Cancer Care Associates LLC Researchers From John Theurer Cancer Center Present Leading-Edge Clinical Data In Blood Cancers At American Society of Hematology Meeting

  December 7, 2015

   · 

  1 min read
• Biotech Bay

  Roche Release: New Results From CLL11 Study Show Gazyva/Gazyvaro Provided People With Previously Untreated Chronic Lymphocytic Leukaemia A Treatment-Free Period Of Nearly Four Years

  December 7, 2015

   · 

  2 min read
• Drug Development

  Adaptive Biotech And Collaborators Present New Data Showing Minimal Residual Disease (MRD) Predicts Relapse And Survival In Chronic Lymphocytic Leukemia (CLL) Patients

  December 7, 2015

   · 

  4 min read
• BioForest

  Juno’s Investigational CAR T Product Candidates JCAR014 And JCAR018 Demonstrate Encouraging Clinical Responses In Patients With B-Cell Cancers

  December 7, 2015

   · 

  8 min read
• Lone Star Bio

  Lexicon Pharma To Present At The Oppenheimer 26th Annual Healthcare Conference

  December 7, 2015

   · 

  2 min read
• Drug Development

  Tolero Pharmaceuticals Presents Data Demonstrating Inhibition Of AXL Kinase In Cancer Cells Restores Drug Sensitivity Through A Mechanism Involving Retinoic Acid Signaling

  December 7, 2015

   · 

  2 min read